INVESTOR RELATIONS

Financial News

Financial News

February 20, 2024
  • North American operating model improvements include progress across manufacturing flexibility, sales execution, pricing power and portfolio expansion
  • Revenue growth management, channel opportunities, digital investments and best-in-class consumer marketing position North America as growth driver
February 6, 2024
CHICAGO, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Mondelēz International, Inc. (Nasdaq: MDLZ) announced that Dirk Van de Put, Chairman & CEO, Luca Zaramella, EVP & Chief Financial Officer and Gustavo Valle, EVP & President North America, will present at the annual Consumer Analyst Group of New York (CAGNY) Conference on February 20 at 3:00 p.m. ET.
February 2, 2024
CHICAGO, Feb. 02, 2024 (GLOBE NEWSWIRE) -- Mondelēz International, Inc. (Nasdaq: MDLZ) today announced the appointment of Brian McNamara to the Company’s Board of Directors, effective Feb. 1. McNamara has served as Chief Executive Officer of Haleon plc, formerly GSK Consumer Healthcare, since May 2022.
January 30, 2024

Full Year Highlights

  • Net revenues for the full year increased +14.4% driven by Organic Net Revenue1 growth of +14.7% with underlying Volume/Mix of +1.3%. For the fourth quarter, Net revenues increased +7.1% driven by Organic Net Revenue1 growth of +9.8% with underlying Volume/Mix of -0.4%
  • Diluted EPS was $3.62, up +84.7%; Adjusted EPS1 was $3.19, up +19.0% on a constant currency basis
  • Year-to-date cash provided by operating activities was $4.7 billion; Free Cash Flow1 was $3.6 billion, up +$0.6 billion vs prior year
  • Return of capital to shareholders was $3.7 billion; increased dividend per share by 10%
  • Closed the divestiture of our developed market gum business for $1.4 billion
  • Expecting for 2024 an on-algorithm year for Organic Net Revenue, Adjusted EPS and Free Cash Flow, with revenue growth at upper end of 3-5% range
November 1, 2023

Third Quarter Highlights

  • Net revenues increased +16.3% driven by Organic Net Revenue1 growth of +15.7% with strong +3.8pp Volume/Mix performance, Volume/Mix positive across all regions
  • Diluted EPS was $0.72, up +84.6%; Adjusted EPS1 was $0.82, up +16.7% on a constant currency basis
  • Year-to-date cash provided by operating activities was $3.2 billion; Free Cash Flow1 was $2.4 billion, up +$0.5 billion vs prior year
  • Return of capital to shareholders was $2.2 billion in the first nine months of the year
  • Closed the divestiture of our developed market gum business for $1.4 billion
  • Raising Organic Net Revenue outlook to 14% to 15% and Adjusted EPS growth outlook to ~16%

Contact